I think we can probably all agree that CSL is a long term company that under promise and over deliver. However, in the short term with the cost pressures faced with easing margins and softer guidance for next year, I would expect PE to reduce to reflect that until plasma side normalises over the next year or so. Some short term disruptions that will present a buying opportunity for those that are patient. I'm looking for anywhere between $240 - 270 myself in terms of a parcel.
Ann: CSL Results Presentation, page-25
-
- There are more pages in this discussion • 42 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add CSL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$292.01 |
Change
-0.990(0.34%) |
Mkt cap ! $141.1B | |||
| Open | High | Low | Value | Volume |
| $292.33 | $292.85 | $290.25 | $152.1M | 521.4K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 591 | $292.00 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $292.01 | 99 | 1 |
View Market Depth
| Last trade - 16.10pm 24/06/2024 (20 minute delay) ? |
| CSL (ASX) Chart |